{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:32:25Z","timestamp":1767835945740,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.drugalcdep.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T02:31:19Z","timestamp":1423708279000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011"],"prefix":"10.1016","volume":"149","author":[{"given":"S.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lintzeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0005","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.36076\/ppj.2014\/17\/E119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0010","series-title":"2013 National Drugs Strategy Household Survey: Key Findings","author":"Australian Institute of Health and Welfare","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0015","series-title":"Alcohol and Other Drug Treatment Services in Australia 2012\u201313","author":"Australian Institute of Health and Welfare","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0020","series-title":"National opioid pharmacotherapy statistics 2013","author":"Australian Institute of Health and Welfare","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999\u20132009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0050","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pds.3522","article-title":"Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics","volume":"22","author":"Coplan","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1440-1584.2006.00775.x","article-title":"Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users","volume":"14","author":"Day","year":"2006","journal-title":"Aust. J. Rural Health"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0060","series-title":"Benefits and Risks of Pharmaceutical Opioids: Essential Treatment and Diverted Medication: A Global Review of Availability, Extra-Medical Use, Injection and the Association with HIV","author":"Degenhardt","year":"2007"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0065","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1360-0443.2005.01051.x","article-title":"Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose","volume":"100","author":"Dietze","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5694\/j.1326-5377.2008.tb01509.x","article-title":"Nurofen Plus misuse: an emerging cause of perforated gastric ulcer","volume":"188","author":"Dutch","year":"2008","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0075","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dar.12025","article-title":"Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada","volume":"32","author":"Fischer","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pds.3404","article-title":"High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005\u20132009","volume":"22","author":"Fischer","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","article-title":"Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005\u20132011","volume":"33","author":"Fischer","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5694\/j.1326-5377.2010.tb03911.x","article-title":"Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases","volume":"193","author":"Frei","year":"2010","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/27.7.499","article-title":"Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases","volume":"27","author":"Kuhlman","year":"2003","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1465-3362.2011.00304.x","article-title":"The availability, diversion and injection of pharmaceutical opioids in South Asia","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40264-014-0193-4","article-title":"Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management","volume":"37","author":"Layton","year":"2014","journal-title":"Drug Saf."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1445-5994.2009.01982.x","article-title":"Examination of opioid prescribing in Australia from 1992 to 2007","volume":"39","author":"Leong","year":"2009","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0130","first-page":"E671","article-title":"Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses","volume":"16","author":"Lusted","year":"2013","journal-title":"Pain Phys."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1465-3362.2011.00291.x","article-title":"The prescription drug epidemic in the United States: a perfect storm","volume":"30","author":"Maxwell","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5694\/j.1326-5377.2011.tb03069.x","article-title":"Misuse of codeine-containing combination analgesics","volume":"194","author":"McDonough","year":"2011","journal-title":"Med. J Aust."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0150","first-page":"367","article-title":"Over-the-counter and prescription medicine misuse in Cape Town \u2013 findings from specialist treatment centres","volume":"93","author":"Myers","year":"2003","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5055\/jom.2011.0077","article-title":"Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention","volume":"7","author":"Nielsen","year":"2011","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0160","doi-asserted-by":"crossref","DOI":"10.1111\/dar.12224","article-title":"Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series","author":"Nielsen","year":"2014","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0165","series-title":"Epidemic Responding to America's prescription Drug Abuse Crisis","author":"ONCDP","year":"2011"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsat.2014.08.002","article-title":"Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance","volume":"48","author":"Oser","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0175","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/pme.12431","article-title":"Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain","volume":"15","author":"Passik","year":"2014","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0180","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5694\/mja12.11843","article-title":"Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia","volume":"199","author":"Pilgrim","year":"2013","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0190","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/ip.2010.029611","article-title":"Increasing deaths involving oxycodone, Victoria, Australia, 2000\u201309","volume":"17","author":"Rintoul","year":"2010","journal-title":"Inj. Prev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09595230500263939","article-title":"The relationship between take-away methadone policies and methadone diversion","volume":"24","author":"Ritter","year":"2005","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0205","series-title":"Drug-Related Hospital Stays in Australia, 1993\u20132012","author":"Roxburgh","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","volume":"32","author":"Roxburgh","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/J354v19n02_04","article-title":"Non-medical use of OxyContin tablets in the United States","volume":"19","author":"Sees","year":"2005","journal-title":"J. Pain. Palliat. Care Pharmacother."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004714-199908000-00014","article-title":"Characteristics of dependent and nondependent regular users of codeine","volume":"19","author":"Sproule","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0225","series-title":"Australian Drug Trend Series No 73","article-title":"Australian drug trends 2011. Findings from the Illicit Drug Reporting System (IDRS)","author":"Stafford","year":"2012"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0230","series-title":"Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008","author":"Substance Abuse and Mental Health Services Administration","year":"2010"},{"key":"10.1016\/j.drugalcdep.2015.02.004_bib0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","article-title":"Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study","volume":"63","author":"Zech","year":"1995","journal-title":"Pain"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161500085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161500085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:15:02Z","timestamp":1651220102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161500085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":47,"alternative-id":["S037687161500085X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.02.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}